Analystreport

Vanda Pharmaceuticals (NASDAQ:VNDA) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report